The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 80 | 5.2x | 20.1x | Above average | |
Growth | 82 | 13.8% | 5.6% | Above average | |
Quality | 43 | -35.7% | 7.6% | Near average | |
Safety | 58 | -1.1x | 0.4x | Near average | |
Capital Return | 95 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Ironwood Pharmaceuticals, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Ironwood Pharmaceuticals, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Ironwood Pharmaceuticals (IRWD) shows a state of complete stability in the average price target at 4.8 dollars over the past 7 and 30-day periods, with an absence of any recent revisions by analysts. This consistency reflects the lack of new catalysts or material data that might drive a change in valuation, while the current price (3.92 dollars) remains below the average target, indicating a technical valuation gap without tangible upward momentum.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.